Recognition of pneumolysin by toll-like receptor 4 confers resistance to pneumococcal infection

被引:523
作者
Malley, R
Henneke, P
Morse, SC
Cieslewicz, MJ
Lipsitch, M
Thompson, CM
Kurt-Jones, E
Paton, JC
Wessels, MR
Golenbock, DT
机构
[1] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA
[2] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[4] Univ Massachusetts, Dept Med, Worcester, MA 01605 USA
[5] Univ Massachusetts, Div Infect Dis, Worcester, MA 01605 USA
[6] Univ Adelaide, Dept Mol Biosci, Adelaide, SA 5005, Australia
关键词
D O I
10.1073/pnas.0435928100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
streptococcus pneumoniae is one of the leading causes of invasive bacterial disease worldwide. Fragments of the cell wall and the cytolytic toxin pneumolysin have been shown to contribute substantially to inflammatory damage, although the interactions between pneumococcal components and host-cell structures have not been elucidated completely. Results of a previous study indicated that cell-wall components of pneumococci are recognized by Toll-like receptor (TLR)2 but suggested that pneumolysin induces inflammatory events independently of this receptor. In this study we tested the hypothesis that pneumolysin interacts with surface proteins of the TLR family other than TLR2. We found that pneumolysin stimulates tumor necrosis factor-alpha and IL-6 release in wild-type macrophages but not in macrophages from mice with a targeted deletion of the cytoplasmic TLR-adapter molecule myeloid differentiation factor 88, suggesting the involvement of the TLRs in pneumolysin recognition. Purified pneumolysin synergistically activated macrophage responses together with preparations of pneumococcal cell walls or staphylococcal peptidoglycan, which are known to activate TLR2. Furthermore, when compared with wild-type macrophages, macrophages from mice that carry a spontaneous mutation in TLR4 (P712H) were hyporesponsive to both pneumolysin alone and the combination of pneumolysin with pneumococcal cell walls. Finally, these TLR4-mutant mice were significantly more susceptible to lethal infection after intranasal colonization with pneumolysin-positive pneumococci than were control mice. We conclude that the interaction of pneumolysin with TLR4 is critically involved in the innate immune response to pneumococcus.
引用
收藏
页码:1966 / 1971
页数:6
相关论文
共 52 条
[1]  
[Anonymous], 1997, MMWR Recomm Rep, V46, P1
[2]  
[Anonymous], 1998, Wkly Epidemiol Rec, V73, P187
[3]   SOME ASPECTS OF THE PNEUMOCOCCAL CARRIER STATE [J].
AUSTRIAN, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :35-45
[4]   PNEUMOCOCCAL BACTEREMIA IN MONROE COUNTY, NEW-YORK [J].
BENNETT, NM ;
BUFFINGTON, J ;
LAFORCE, FM .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1992, 82 (11) :1513-1516
[5]   The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model [J].
Benton, KA ;
Paton, JC ;
Briles, DE .
MICROBIAL PATHOGENESIS, 1997, 23 (04) :201-209
[6]   REDUCED VIRULENCE OF A DEFINED PNEUMOLYSIN-NEGATIVE MUTANT OF STREPTOCOCCUS-PNEUMONIAE [J].
BERRY, AM ;
YOTHER, J ;
BRILES, DE ;
HANSMAN, D ;
PATON, JC .
INFECTION AND IMMUNITY, 1989, 57 (07) :2037-2042
[7]   EFFECT OF DEFINED POINT MUTATIONS IN THE PNEUMOLYSIN GENE ON THE VIRULENCE OF STREPTOCOCCUS-PNEUMONIAE [J].
BERRY, AM ;
ALEXANDER, JE ;
MITCHELL, TJ ;
ANDREW, PW ;
HANSMAN, D ;
PATON, JC .
INFECTION AND IMMUNITY, 1995, 63 (05) :1969-1974
[8]   Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[9]   Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages [J].
Braun, JS ;
Novak, P ;
Gao, GL ;
Murray, PJ ;
Shenep, JL .
INFECTION AND IMMUNITY, 1999, 67 (08) :3750-3756
[10]  
Braun JS, 2002, J CLIN INVEST, V109, P19